Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Securities Purchase Agreement [Member]
Sale of Stock [Axis]
July Offering [Member]
July 2024 Registered Direct Offering [Member]
Financial Instrument [Axis]
US Treasury Securities [Member]
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Lender Name [Axis]
Silicon Valley Bank [Member]
Market Offering Agreement [Member]
ATM Agreement [Member]
Warrant [Member]
Plan Name [Axis]
2018 Stock Incentive Plan [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Inducement Option Grants [Member]
Title and Position [Axis]
Board of Directors Chairman [Member]
Award Type [Axis]
Restricted Stock [Member]
Equity Stock Awards [Member]
Scenario [Axis]
Granted Under 2018 Plan and 2007 Plan [Member]
Inducement Awards [Member]
Stock Options and Restricted Stock Awards [Member]
Statement of Income Location, Balance [Axis]
Research and Development Expense [Member]
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Option [Member]
Lease Agreement [Member]
Convertible Note Purchase Agreement [Member]
Legal Entity [Axis]
Transomic Technologies, Inc. [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Statement of Financial Position [Abstract]
ASSETS
Current assets:
Cash and cash equivalents
Investment in debt securities - available for sale, at fair value
Advances and deposits on clinical programs and other current assets
Total current assets
Property and equipment, net (at cost, less accumulated depreciation and amortization)
Other assets:
Deferred income tax asset
Operating lease right-of-use assets, net
Deposits and other assets
Total other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable – trade
Other accrued liabilities
Operating lease liabilities - current portion
Total current liabilities
Operating lease liabilities - non-current portion
Total liabilities
Commitments and contingencies
Stockholders’ equity:
Preferred stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at September 30, 2024 and December 31, 2023)
Common stock - $0.01 par value (112,500,000 shares authorized; 14,500,707 and 9,399,811 shares issued at September 30, 2024 and December 31, 2023, respectively, and 14,500,685 and 9,399,789 shares outstanding at September 30, 2024 and December 31, 2023, respectively)
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity before treasury stock
Treasury stock, at cost (22 shares at September 30, 2024 and December 31, 2023)
Total stockholders’ equity
Total liabilities and stockholders’ equity
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, shares
Income Statement [Abstract]
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Investment income, net
Interest expense on loan facility
Loss on extinguishment of debt
Total other income (expense), net
Net loss
Net loss per common share
Basic
Diluted
Weighted average shares outstanding
Basic
Diluted
Statement of Comprehensive Income [Abstract]
Other comprehensive loss
Changes in:
Change in realized and unrealized losses on available for sale securities, net
Net loss
Total comprehensive loss
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Amortization of right-of-use assets
Realized gains, net, on investment securities
Stock-based compensation
Realization of deferred income tax asset
Loss on extinguishment of debt
Amortization of deferred finance charges and debt discount associated with notes payable
Net changes in:
Accrued interest on investment securities
Advances, deposits, and other current assets
Accounts payable and accrued liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchases of investment securities
Proceeds from sale and maturity of investment securities
Purchases of property and equipment
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from sale of common stock equity, net of issuance costs
Payoff of the SVB loan and accrued end-of-term fees
Net cash provided by (used in) financing activities
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosures of cash flow information:
Interest paid
Non-cash investing and financing activities:
Recognition of operating lease right-of-use asset and liability
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Sale of equity through equity financing facilities, net of issuance costs
Sale of equity through equity financing facilities, net of issuance costs, shares
Issuance of common stock upon exercise of restricted stock
Issuance of common stock upon exercise of restricted stock, shares
Stock-based compensation expense
Realized and unrealized gains (losses), net, on investments securities
Issuance of common stock upon exercise of restricted stock
Issuance of common stock upon exercise of restricted stock, shares
Issuance of common stock for restricted stock
Issuance of common stock upon exercise of restricted stock, shares
Balance
Balance, shares
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Rule 10b5-1 Arrangement Modified
Non-Rule 10b5-1 Arrangement Modified
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Accounting Policies [Abstract]
Business Description
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements
Earnings Per Share [Abstract]
Net Loss per Common Share
Investments, Debt and Equity Securities [Abstract]
Investment in Debt Securities - Available for Sale
Fair Value Disclosures [Abstract]
Fair Value Measurements
Payables and Accruals [Abstract]
Other Accrued Liabilities
Debt Disclosure [Abstract]
Notes Payable
Equity [Abstract]
Stockholders’ Equity
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation
Warrants
Warrants
Leases [Abstract]
Leases
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Related Party Transactions [Abstract]
Related Party Transaction
Subsequent Events [Abstract]
Subsequent Events
Schedule of Cost, Fair Value and Maturities of Short Term Investments
Summary of Investment Securities Gross Unrealized Gains (Losses)
Summary of Net Realized Losses on Sales of Available for Sale Securities and Investment Income Interest and Dividends
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
Schedule of Other Accrued Liabilities
Summary of Stock Options Awards and Restricted Stock Grants
Schedule of Assumptions Used to Determine Fair Value of Options Granted
Summary of Warrant Activity
Schedule of Lease Payments and Maturity of Operating Lease Liabilities
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net loss
Cash to fund operation
Cumulative net loss
Cash and cash equivalents, short-term investments, and interest receivable
Stock Issued During Period, Shares, New Issues
Share Price
Proceeds from Issuance of Common Stock
Class of Warrant or Right, Exercise Price of Warrants or Rights
Anti-dilutive securities
Marketable Securities [Table]
Marketable Securities [Line Items]
Short-term investments - Cost
Short-term investments - Fair Value
Short-term investment maturities - Within 3 months, cost
Short-term investment maturities - Within 3 months, fair value
Short-term investment maturities - Between 3-12 months, cost
Short-term investment maturities - Between 3-12 months, fair value
Short-term investment maturities - cost
Short-term investment maturities - fair value
Investments in debt securities with unrealized gains - Fair Value
Investments in debt securities with unrealized gains - Unrealized Holding Gains
Interest and dividends accrued and paid
Realized gains (losses) on investment in debt securities
Investment income, net
Debt securities, available for sale, current
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amounts due to contract research organizations and other contractual agreements
Accrued payroll and related benefits
Accrued professional fees
Other
Total
Line of Credit Facility [Table]
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity
Proceeds from line of credit loan
Repayments of lines of credit
Restricted cash
Final payment percentage
Long term line of credit
Financing fees and expenses
End of term charge percentage
Interest expense debt
Interest expense
Amortization of debt issuance costs
Gain (loss) on contract termination
Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]
Subsidiary, Sale of Stock [Line Items]
Stock issued during period, value, new issues
Proceeds from issuance of common stock
Number of shares sold
Proceeds from sale of stock
Stock issued, shares
Share price
Placement agent fee description
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding, beginning balance
Weighted average exercise price, beginning balance
Non-vested stock awards, beginning balance
Weighted average grant date fair value, beginning balance
Options outstanding, granted
Weighted average exercise price, granted
Non-vested stock awards, granted
Weighted average grant date fair value, granted
Options outstanding, vested and issued
Weighted average exercise price, vested and issued
Non-vested stock awards, vested and issued
Weighted average grant date fair value, vested and issued
Options outstanding, Terminated
Weighted average exercise price, Terminated
Non-vested stock awards, Terminated
Weighted average grant date fair value, Terminated
Options outstanding, ending balance
Weighted average exercise price, ending balance
Non-vested stock awards, ending balance
Weighted average grant date fair value, ending balance
Weighted average contractual terms
Options outstanding, aggregate intrinsic value
Options outstanding, exercisable
Weighted average exercise price, exercisable
Weighted average contractual terms, exercisable
Options outstanding, aggregate intrinsic value, exercisable
Risk-free interest rate
Expected volatility
Expected life (in years)
Expected dividend yield
Share-based payment award, shares authorized
Shares available for issuance
Stock options, strike price description
Shares issued
Options granted, weighted average exercise price
Common stock, reserved for future issuance
Share based compensation
Unrecognized share based compensation
Unrecognized share based compensation, period
Summary Of Warrant Activity
Number of Warrants Issued, Warrants outstanding, Beginning balance
Weighted Average Exercise Price, Warrants outstanding, Beginning balance
Number of Warrants Issued, Warrants issued
Weighted Average Exercise Price, Warrants issued
Number of Warrants Issued, Warrants expired
Weighted Average Exercise Price, Warrants expired
Number of Warrants Issued, Warrants outstanding, Ending balance
Weighted Average Exercise Price, Warrants outstanding, Ending balance
Aggregate intrinsic value of outstanding warrants
Weighted average remaining contractual terms (years)
2024
2025
2026
2027
2028 and thereafter
Subtotal future lease payments
Less: imputed interest
Total lease liabilities
Operating lease, weighted average remaining lease term
Operating lease, weighted average discount rate, percent
Operating lease, term
Area of land
Payments for rent
Operating lease, cost
Operating lease, payments
Convertable and warrants
Rule 10b5-1 Arrangement Modified.
Non-Rule 10b5-1 Arrangement Modified.
Amortization of deferred finance charges and debt discount associated with notes payable.
Payoff of the SVB loan and accrued end-of-term fees.
Recognition of right of use asset and liability.
Cumulative net income loss
Securities Purchase Agreement [Member]
July 2024 Registered Direct Offering [Member]
Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) with single maturity date and allocated without single maturity date, maturing in next rolling three months.
Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three to twelve months.
The current amount of amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three to twelve months.
Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three months.
Available for sale securities unrealized losses fair value.
Available for sale securities unrealized gain less than twelve months.
Silicon Valley Bank [Member]
Final Payment Percentage.
End of term charge percentage.
Market Offering Agreement [Member]
July Offering [Member]
Placement agent fee description.
2018 Stock Incentive Plan [Member]
Stock options, strike price description.
Inducement Option Grants [Member]
Equity Stock Awards [Member]
Granted Under 2018 Plan and 2007 Plan [Member]
Inducement Awards [Member]
Stock Options and Restricted Stock Awards [Member]
Summary of Stock Option and Restricted Stock Awards [Table Text Block]
Share based compensation arrangement by share based payment award options vested and issued in period.
Share based compensation arrangement by share based payment award options vested and issued in period weighted average exercise price.
Disclosure of warrants.
Sharebased compensation arrangement by sharebased payment award non options outstanding intrinsic value.
Weighted average remaining contractual term for non-option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.
Weighted Average Exercise Price, Warrants issued.
Weighted Average Exercise Price, Warrants expired.
Lease Agreement [Member]
Lessee operating lease liability payments due year four and after year year.
Convertible Note Purchase Agreement [Member]
Transomic Technologies, Inc. [Member]
ATM Agreement [Member]
Assets, Current
Other Assets, Noncurrent
Assets
Liabilities, Current
Liabilities
Stockholders' Equity before Treasury Stock
Treasury Stock, Value
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Operating Income (Loss)
Interest Expense, Nonoperating
Nonoperating Income (Expense)
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Diluted
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Gain (Loss) on Investments
Increase (Decrease) in Accrued Investment Income Receivable
Increase (Decrease) in Other Current Assets
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Debt Securities, Available-for-Sale
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
PaymentoffOfLoanAndAccruedEndoftermFees
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Interest Paid, Excluding Capitalized Interest, Operating Activities
Shares, Outstanding
Stock Issued During Period, Value, Stock Options Exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Stock Issued During Period, Shares, Restricted Stock Award, Gross
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Warrants [Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount